PE20161559A1 - Peptidos como agonistas de la oxitocina - Google Patents
Peptidos como agonistas de la oxitocinaInfo
- Publication number
- PE20161559A1 PE20161559A1 PE2016002397A PE2016002397A PE20161559A1 PE 20161559 A1 PE20161559 A1 PE 20161559A1 PE 2016002397 A PE2016002397 A PE 2016002397A PE 2016002397 A PE2016002397 A PE 2016002397A PE 20161559 A1 PE20161559 A1 PE 20161559A1
- Authority
- PE
- Peru
- Prior art keywords
- hydrogen
- lower alkyl
- peptides
- compounds
- chr4
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Addiction (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se refiere a un compuesto de formula I, donde: R1 es hidrogeno, alquilo inferior o cicloalquilo; R2 es hidrogeno; o R1 y R2 pueden forman junto con el atomo de N y C al que se unen un anillo pirrolidina, una azetidina o un anillo piperazina; R3 es hidrogeno, alquilo inferior, entre otros; R3 es hidrogeno o alquilo inferior; X es C(O)-CHR4-CHR4-C(O)-NH-CH2-; R4 y R4 son hidrogeno o uno de R4 o R4 es amino; o es 0 o 1. Son compuestos preferidos los compuestos de formula i, ii, entre otros. Tambien se refiere a una composicion farmaceutica. Dichos compuestos son peptidos agonistas del receptor de la oxitocina, siendo utiles en el tratamiento del autismo, el estres, entre otros.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14170992 | 2014-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20161559A1 true PE20161559A1 (es) | 2017-01-12 |
Family
ID=50842169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2016002397A PE20161559A1 (es) | 2014-06-03 | 2015-06-01 | Peptidos como agonistas de la oxitocina |
Country Status (16)
Country | Link |
---|---|
US (1) | US9957298B2 (es) |
EP (1) | EP3151849B1 (es) |
JP (1) | JP6412170B2 (es) |
KR (1) | KR20170004013A (es) |
CN (1) | CN106414479B (es) |
AU (1) | AU2015270723A1 (es) |
CA (1) | CA2949173A1 (es) |
CL (1) | CL2016003095A1 (es) |
CR (1) | CR20160563A (es) |
EA (1) | EA030091B1 (es) |
IL (1) | IL248553A0 (es) |
MX (1) | MX2016015873A (es) |
PE (1) | PE20161559A1 (es) |
PH (1) | PH12016502232A1 (es) |
SG (1) | SG11201610073PA (es) |
WO (1) | WO2015185467A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI3666258T1 (sl) | 2014-09-19 | 2024-04-30 | Ferring Bv | Postopek zdravljenja Prader-Willijevega sindroma |
WO2019060962A1 (en) * | 2017-09-28 | 2019-04-04 | The University Of Sydney | SELECTIVE AGONISTS OF THE OCYTOCIN RECEPTOR, INSPIRED BY METABOLITES |
EP3852723A4 (en) * | 2018-09-20 | 2022-06-29 | Levo Therapeutics, Inc. | Stable intranasal formulations of carbetocin |
TW202034899A (zh) | 2018-09-20 | 2020-10-01 | 克里斯托弗 S 布萊恩特 | 卡貝縮宮素藥品及其製備方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9701162D0 (sv) * | 1997-03-27 | 1997-03-27 | Karolinska Innovations Ab | New use II |
KR20070022753A (ko) * | 2004-05-26 | 2007-02-27 | 화이자 인코포레이티드 | 인다졸 및 인돌론 유도체 및 이의 약제로서의 용도 |
EA026578B1 (ru) * | 2007-01-22 | 2017-04-28 | ДЖиТиЭкс, ИНК. | Вещества, связывающие ядерные рецепторы |
EP2260053B1 (en) * | 2008-03-31 | 2014-05-14 | Ferring BV | Oxytocin analogues |
WO2010034656A1 (en) * | 2008-09-23 | 2010-04-01 | F. Hoffmann-La Roche Ag | Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulatorsof dopamine d3 receptors |
MX2011011477A (es) * | 2009-05-05 | 2011-11-18 | Hoffmann La Roche | Derivados de isoxazol-piridazina. |
TWI463990B (zh) * | 2009-09-21 | 2014-12-11 | Ferring Bv | 催產素受體促進劑 |
EP2482835B1 (en) * | 2009-10-01 | 2014-07-02 | The University Of Sydney | Therapy and prevention of problem drinking |
DK2935312T3 (en) | 2012-12-21 | 2018-10-22 | Hoffmann La Roche | Peptides as oxytocin agonists |
-
2015
- 2015-06-01 CA CA2949173A patent/CA2949173A1/en not_active Abandoned
- 2015-06-01 JP JP2016571027A patent/JP6412170B2/ja not_active Expired - Fee Related
- 2015-06-01 AU AU2015270723A patent/AU2015270723A1/en not_active Abandoned
- 2015-06-01 SG SG11201610073PA patent/SG11201610073PA/en unknown
- 2015-06-01 CR CR20160563A patent/CR20160563A/es unknown
- 2015-06-01 WO PCT/EP2015/062054 patent/WO2015185467A1/en active Application Filing
- 2015-06-01 EA EA201692404A patent/EA030091B1/ru not_active IP Right Cessation
- 2015-06-01 MX MX2016015873A patent/MX2016015873A/es unknown
- 2015-06-01 PE PE2016002397A patent/PE20161559A1/es unknown
- 2015-06-01 CN CN201580027370.7A patent/CN106414479B/zh not_active Expired - Fee Related
- 2015-06-01 KR KR1020167036060A patent/KR20170004013A/ko not_active Application Discontinuation
- 2015-06-01 EP EP15725359.2A patent/EP3151849B1/en not_active Not-in-force
-
2016
- 2016-10-27 IL IL248553A patent/IL248553A0/en unknown
- 2016-11-09 PH PH12016502232A patent/PH12016502232A1/en unknown
- 2016-12-01 CL CL2016003095A patent/CL2016003095A1/es unknown
- 2016-12-02 US US15/368,080 patent/US9957298B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN106414479A (zh) | 2017-02-15 |
AU2015270723A1 (en) | 2016-11-17 |
US9957298B2 (en) | 2018-05-01 |
SG11201610073PA (en) | 2016-12-29 |
WO2015185467A1 (en) | 2015-12-10 |
CL2016003095A1 (es) | 2017-06-16 |
EP3151849B1 (en) | 2018-10-10 |
KR20170004013A (ko) | 2017-01-10 |
US20170081369A1 (en) | 2017-03-23 |
JP6412170B2 (ja) | 2018-10-24 |
CN106414479B (zh) | 2021-08-03 |
PH12016502232A1 (en) | 2017-01-09 |
EA030091B1 (ru) | 2018-06-29 |
CA2949173A1 (en) | 2015-12-10 |
IL248553A0 (en) | 2016-12-29 |
EP3151849A1 (en) | 2017-04-12 |
CR20160563A (es) | 2017-01-06 |
JP2017518311A (ja) | 2017-07-06 |
EA201692404A1 (ru) | 2017-05-31 |
MX2016015873A (es) | 2017-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016002348A1 (es) | Agonistas del receptor muscarínico | |
CO2017013709A2 (es) | Lactamas bicíclicas. | |
DOP2018000257A (es) | Piridinas sustituidas con heteroarilo y métodos de uso | |
PE20170427A1 (es) | Peptidos como agonistas de la oxitocina | |
UY32547A (es) | Piperidinas sustituidas como antagonistas de ccr3 | |
PE20190711A1 (es) | N-(fenils ulfonil) benzamidas y compuestos relacionados como inhibidores de bcl-2 | |
CL2018000953A1 (es) | 2,4-dihidroxi-nicotinamidas como agonistas del receptor de apelina (apj) | |
CU20160180A7 (es) | Compuestos de dihidroisoquinolinona sustituida | |
CL2017002452A1 (es) | Nuevos compuestos bicíclicos | |
PE20161572A1 (es) | Compuestos como moduladores de ror gamma | |
PE20180024A1 (es) | Triazolopirazinonas como inhibidores de pde1 | |
PE20151558A1 (es) | Inhibidores tripeptidicos de la epoxicetona proteasa | |
UY35143A (es) | Derivados de dihidropirazol como moduladores del receptor acoplado a la proteína gpr40 g | |
PE20151060A1 (es) | Nuevos derivados de pirazina como agonistas del receptor cb2 | |
UY35305A (es) | Compuestos sustituidos como moduladores de la pro teína de activación de la 5-lipoxigenasa (flap) | |
PE20161444A1 (es) | 1,2-ciclopentanos sustituidos como antagonistas del receptor de orexina | |
PE20161407A1 (es) | Piridina 5,6 disustituida -2-carboxamidas como agonistas del receptor canabinoide | |
PE20161559A1 (es) | Peptidos como agonistas de la oxitocina | |
PE20180355A1 (es) | Desacetoxitubulisina h y analogos de esta | |
CO2018007663A2 (es) | Compuestos indolinonas y su uso en el tratamiento de enfermedades fibróticas | |
CR20160448A (es) | Nuevos derivados de piridina | |
CL2021000421A1 (es) | Nuevo derivado de amina heterocíclico y composición farmacéutica que lo comprende. | |
CU24630B1 (es) | Triazolobenzazepinas como antagonistas del receptor v1a de la vasopresina | |
ES2568909T3 (es) | Novedosos compuestos antagonistas del receptor de la neuroquinina 1 | |
ECSP11011415A (es) | Piperidinas sustituidas como antagonistas de ccr3. |